Skip to main content
SpringerLink
Log in

The Asthma–COPD Overlap Syndrome (ACOS): What Is the Significance COPD Associated with Asthma?

  • Chapter
  • First Online:
Chronic Obstructive Pulmonary Disease

  • 3125 Accesses

Abstract

Asthma is characterized by inflammation involving eosinophils and Th2 cytokines of the central to peripheral airways, with high reversibility of the airflow obstruction (hereafter simply, airflow reversibility). On the other hand, chronic obstructive pulmonary disease (COPD) is characterized by inflammation involving neutrophils and inflammatory cytokines of the peripheral airways to the alveoli, with low or no airflow reversibility. The asthma-COPD overlap syndrome (ACOS) is characterized by features of both and associated with moderate airflow reversibility. ACOS does not uniformly have the features of asthma or COPD, and its features depend on the type and major site of airway inflammation. The medical costs of ACOS are higher than those of either asthma or COPD. Under such circumstances, the Global Initiative for Asthma (GINA) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) have provided guidelines for the management of ACOS. It is important to combine treatments for both COPD and asthma and not use treatment for either alone in patients with AOCS.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Saglani S, Lloyd CM. Eosinophils in the pathogenesis of paediatric severe asthma. Curr Opin Allergy Clin Immunol. 2014;14:143–8.

    Article  CAS  PubMed  Google Scholar 

  2. Koch S, Finotto S. Role of interferon-λ in allergic asthma. J Innate Immun. 2015;7:224–30.

    Article  CAS  PubMed  Google Scholar 

  3. Fahy JV. Type 2 inflammation in asthma–present in most, absent in many. Nat Rev Immunol. 2015;15:57–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wang F, Ni SS, Liu H. Pollutional haze and COPD: etiology, epidemiology, pathogenesis, pathology, biological markers and therapy. J Thorac Dis. 2016;8:E20–30.

    PubMed  PubMed Central  Google Scholar 

  5. Papaiwannou A, Zarogoulidis P, Porpodis K, Spyratos D, Kioumis I, Pitsiou G, Pataka A, Tsakiridis K, Arikas S, Mpakas A, Tsiouda T, Katsikogiannis N, Kougioumtzi I, Machairiotis N, Siminelakis S, Kolettas A, Kessis G, Beleveslis T, Zarogoulidis K. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis. 2014;6 Suppl 1:S146–51.

    PubMed  PubMed Central  Google Scholar 

  6. Orie NG, Slutter HJ, de Vries, Tammeling GJ. Chronic nonspecific respiratory diseases. Ned Tijdschr Geneeskd. 1961;105:2136–9. Article in Dutch.

    Google Scholar 

  7. Sluiter HJ, Koëter GH, de Monchy JG, Postma DS, de Vries K, Orie NG. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J. 1991;4:479–89.

    CAS  PubMed  Google Scholar 

  8. Hernández G, Avila M, Pont A, Garin O, Alonso J, Laforest L, Cates CJ, Ferrer M, ASTRO-LAB group. Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies. Respir Res. 2014;15:83.

    PubMed  PubMed Central  Google Scholar 

  9. Nelson HS, Gallegos CM, Silveira LJ, Newell JD, Gelfand EW. Effect of the inhaled corticosteroid mometasone on small airway patency in patients with asthma. Allergy Asthma Proc. 2009;30:284–92.

    Article  CAS  PubMed  Google Scholar 

  10. Tabberer M, Brooks J, Wilcox T. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2015;13:177.

    Article  PubMed  PubMed Central  Google Scholar 

  11. The Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2015. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma-COPD Overlap Syndrome (ACOS) Available http://www.ginasthma.org/local/uploads/files/ACOS_2015.pdf. Accessed Jan 31 2016.

  12. Burrows B, et al. Epidemiologic observations on eosinophilia and its relation to respiratory disorders. Am Rev Respir Dis. 1980;122:709–19.

    Article  CAS  PubMed  Google Scholar 

  13. Taylor RG, Gross E, Joyce H, Holland F, Pride NB. Smoking, allergy, and the differential white blood cell count. Thorax. 1985;40:17–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Reid L. The role of chronic bronchitis in the production of “chronic obstructive pulmonary emphysema”. J Am Med Womens Assoc. 1965;20:633–8.

    CAS  PubMed  Google Scholar 

  15. Elias JA, Kang MJ, Crothers K, Homer R, Lee CG. State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice. Proc Am Thorac Soc. 2006;3:494–8.

    Article  CAS  PubMed  Google Scholar 

  16. Kesten S, Rebuck AS. Is the short-term response to inhaled β-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD? Chest. 1994;105:1042–5.

    Article  CAS  PubMed  Google Scholar 

  17. Gelb AF, Zamel N. Unsuspected pseudophysiologic emphysema in chronic persistent asthma. Am J Respir Crit Care Med. 2000;162:1778–82.

    Article  CAS  PubMed  Google Scholar 

  18. Matsumoto K, Seki N, Fukuyama S, Moriwaki A, Kan-o K, Matsunaga Y, Noda N, Yoshida M, Koto H, Takata S, Nakanishi Y, Kiyohara Y, Inoue H, Hisayama Pulmonary Physiology Study Group. Prevalence of asthma with airflow limitation, COPD, and COPD with variable airflow limitation in older subjects in a general Japanese population: the Hisayama Study. Respir Investig. 2015;53:22–9.

    Article  PubMed  Google Scholar 

  19. Andersén H, Lampela P, Nevanlinna A, Säynäjäkangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J. 2013;7:342–6.

    Article  PubMed  Google Scholar 

  20. de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, Casali L, Ferrari M, Nicolini G, Panico MG, Pirina P, Zanolin ME, Cerveri I, Verlato G. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8, e62985.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Menezes AM, Montes de Oca M, Pérez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, Muiño A, Jardim JR, Valdivia G, Tálamo C, PLATINO Team. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145:297–304.

    Article  PubMed  Google Scholar 

  22. Cosio BG, Soriano JB, López-Campos JL, Calle-Rubio M, Soler-Cataluna JJ, de-Torres TP, Marín JM, Martínez-Gonzalez C, de Lucas P, Mir I, Peces-Barba G, Feu-Collado N, Solanes I, Alfageme I, Casanova C, CHAIN Study. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016;149:45–52.

    Article  PubMed  Google Scholar 

  23. Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, Crapo JD, Hersh CP, COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wurst KE, Kelly-Reif K, Bushnell GA, Pascoe S, Barnes N. Understanding asthma-chronic obstructive pulmonary disease overlap syndrome. Respir Med. 2016;110:1–11.

    Article  PubMed  Google Scholar 

  25. Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax. 2015;70:683–91.

    Article  PubMed  Google Scholar 

  26. Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J. 2002;20:819–25.

    Article  CAS  PubMed  Google Scholar 

  27. Milanese M, Di Marco F, Corsico AG, Rolla G, Sposato B, Chieco-Bianchi F, Costantino MT, Crivellaro MA, Guarnieri G, Scichilone N, ELSA Study Group. Asthma control in elderly asthmatics. An Italian observational study. Respir Med. 2014;108:1091–9.

    Article  CAS  PubMed  Google Scholar 

  28. Ohta K, Ichinose M, Nagase H, Yamaguchi M, Sugiura H, Tohda Y, Yamauchi K, Adachi M, Akiyama K, Japanese Society of Allergology. Japanese guideline for adult asthma 2014. Allergol Int. 2014;63:293–333.

    Article  CAS  PubMed  Google Scholar 

  29. Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpeläinen M, Kinnula VL, Haahtela T, Laitinen T. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48:279–85.

    Article  PubMed  Google Scholar 

  30. Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD Overlap Syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10, e0136065.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Gerhardsson de Verdier M, Andersson M, Kern DM, Zhou S, Turnceli O. Asthma and chronic obstructive pulmonary disease overlap syndrome: doubled costs compared with patients with asthma alone. Value Health. 2015;18:759–66.

    Article  PubMed  Google Scholar 

  32. Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, Dalal A, Scharf SM. Burden of concomitant asthma and COPD in a Medicaid population. Chest. 2008;134:14–9.

    Article  PubMed  Google Scholar 

  33. Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med. 2008;102:50–6.

    Article  CAS  PubMed  Google Scholar 

  34. Yoshida M, Nakano T, Fukuyama S, Matsumoto T, Eguchi M, Moriwaki A, Takata S, et al. Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes. Pulm Pharmacol Ther. 2013;26:159–66.

    Article  CAS  PubMed  Google Scholar 

  35. Alvarado-Gonzalez A, Arce I. Tiotropium bromide in chronic obstructive pulmonary disease and bronchial asthma. J Clin Med Res. 2015;7:831–9.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Lim HS, Choi SM, Lee J, Park YS, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Lee CH. Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome. Ann Allergy Asthma Immunol. 2014;113:652–7.

    Article  CAS  PubMed  Google Scholar 

  37. To T, Zhu J, Larsen K, Simatovic J, Feldman L, Ryckman K, Gershon A, Lougheed MD, Licskai C, Chen H, Villeneuve PJ, Crighton E, Su Y, Sadatsafavi M Williams D, Carlsten C, Canadian Respiratory Research Network. Progression from asthma to Chronic Obstructive Pulmonary Disease (COPD): is air pollution a risk factor?. Am J Respir Crit Care Med. 2016 [Epub ahead of print].

    Google Scholar 

  38. de Marco R, Marcon A, Rossi A, Antó JM, Cerveri I, Gislason T, Heinrich J, Janson C, Jarvis D, Kuenzli N, Leynaert B, Probst-Hensch N, Svanes C, Wjst M, Burney P. Asthma, COPD and overlap syndrome: a longitudinal study in young European adults. Eur Respir J. 2015;46:671–9.

    Article  PubMed  Google Scholar 

  39. Spears M, McSharry C, Chaudhuri R, Weir CJ, de Wet C, Thomson NC. Smoking in asthma is associated with elevated levels of corticosteroid resistant sputum cytokines-an exploratory study. PLoS One. 2013;8, e71460.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C, Larfferty J, Chaudhuri R, Braganza G, Adcock IM, Barnes PJ, Wood S, Thomson NC. Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study. Eur Respir J. 2009;33:1010–7.

    Article  CAS  PubMed  Google Scholar 

  41. Rhee CK, Yoon HK, Yoo KH, Kim YS, Lee SW, Park YB, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD. 2013;11:163–70.

    Article  PubMed  Google Scholar 

  42. Izquierdo-Alonso JL, Rodriguez-Gonzálezmoro JM, de Lucas-Ramos P, Unzueta I, Ribera X, Antón E, et al. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). Respir Med. 2013;107:724–31.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases and Prevention, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan

    Hidehiro Watanabe

Authors
  1. Hidehiro Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hidehiro Watanabe .

Editor information

Editors and Affiliations

  1. Department of Respiratory Medicine, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan

    Hiroyuki Nakamura

  2. Department of Respiratory Medicine, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan

    Kazutetsu Aoshiba

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Watanabe, H. (2017). The Asthma–COPD Overlap Syndrome (ACOS): What Is the Significance COPD Associated with Asthma?. In: Nakamura, H., Aoshiba, K. (eds) Chronic Obstructive Pulmonary Disease. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer, Singapore. https://doi.org/10.1007/978-981-10-0839-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-0839-9_16

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-0838-2

  • Online ISBN: 978-981-10-0839-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation